Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 5.430
-0.070 (-1.27%)
Nov 2, 2026, 5:08 PM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 348.14 million as of November 2, 2026. It is the 32,481st most valuable company in the world and the 439th biggest in Sweden. Its market cap has decreased by 8.14% in one year.
Market Cap
348.14M
Enterprise Value
306.19M
Revenue
n/a
Global Rank
Country Rank
#439 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 348.14M, an increase of 197.33%. That is a compound annual growth rate of 8.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 348.14M | 1.53% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 663.69M |
| Xspray Pharma AB | 573.74M |
| FluoGuide | 498.65M |
| Cantargia AB | 457.88M |
| Sprint Bioscience AB | 381.97M |
| Isofol Medical AB | 379.46M |
| Corline Biomedical AB | 369.78M |
| IRLAB Therapeutics AB | 303.37M |